首页> 美国卫生研究院文献>Health Psychology Research >Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients
【2h】

Pharmacological and Non-pharmacological Treatment Options for Depression and Depressive Symptoms in Hemodialysis Patients

机译:血液透析患者抑郁和抑郁症状的药物和非药物治疗选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Depression is a mental disorder with a high prevalence among patients with end stage renal disease (ESRD). It is reported that depression afflicts approximately 20-30% of this patient population, being associated, amongst other, with high mortality rate, low adherence to medication and low perceived quality of life. There is a variety of medications known to be effective for the treatment of depression but due to poor adherence to treatment as well as due to the high need for medications addressing other ESRD comorbidities, depression often remains untreated. According to the literature, depression is under-diagnosed and undertreated in the majority of the patients with chronic kidney disease. In the current review the main pharmacological and non-pharmacological approaches and research outcomes for the management of depressive symptoms in hemodialysis patients are discussed.
机译:抑郁症是终末期肾病(ESRD)患者中的一种精神疾病,患病率很高。据报道,抑郁症困扰着该患者人群的约20-30%,其中包括死亡率高,对药物的依从性低和感知的生活质量低。已知有多种药物可有效治疗抑郁症,但由于治疗依从性差以及对其他ESRD合并症的药物需求旺盛,抑郁症通常仍未得到治疗。根据文献,大多数慢性肾脏病患者的抑郁症诊断不足,治疗不足。在本综述中,讨论了血液透析患者抑郁症状管理的主要药理和非药理方法以及研究成果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号